The Medigene Share
The Medigene share MDG1 (ISIN:DE000A1X3W00 ) is listed at the Frankfurt Stock Exchange since June 2000.
Investors & Media
Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.
Latest News
Medigene presents new data on reproducible production of TCR-T cells from MDG1011 program
Events
29
Mar 2023
Annual Report 2022
03
May 2023
Quarterly Statement Q1 2023
02
Aug 2023
6-Months Report 2023
10
Aug 2023
Annual General Meeting 2023
26
Oct 2023
Quarterly Statement Q3 2023
Corporate Governance
Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.
Contact person
investor(at)medigene.com
Phone: +49 89 2000 3333 01
Fax: +49 89 2000 33 2920